- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06376175
Task Atlas: Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program
April 18, 2024 updated by: Lumos Labs, Inc.
Task Atlas: An Observational Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program
Healthy volunteers ages 25-40 from the general US population who meet the eligibility criteria and are enrolled will (a) play Lumosity games at least 20 times each in under 60 days and (b) then complete one session of task-based functional magnetic resonance imaging (fMRI) while playing Lumosity games.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bob Schafer, PhD
- Phone Number: (530) 746-8565
- Email: bschafer@lumoslabs.com
Study Contact Backup
- Name: Kelsey Kerlan, BSN
- Email: taskatlas@lumoslabs.com
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- UC Davis Imaging Research Center (IRC)
-
Contact:
- Kevin Madore, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Healthy adults age 25-40
Description
Inclusion Criteria:
- Subjects 25-40 years of age.
- Ability to understand and speak English, follow written and verbal instructions (English), and give informed consent (English), as assessed by the PI or project manager.
- Ability to comply with all the testing and study requirements, including the ability to independently complete daily, online Lumosity games on a reliable, internet-connected device.
- Geographical location within 100 miles of the study imaging center.
Exclusion Criteria:
- Current, controlled (requiring treatment) or uncontrolled psychiatric diagnosis, including but not limited to posttraumatic stress disorder, psychosis, bipolar illness, pervasive developmental disorder, severe obsessive compulsive disorder, severe depressive or severe anxiety disorder, conduct disorder, attention- deficit/hyperactivity disorder, or other symptomatic manifestations that in the opinion of the PI may confound study data/assessments.
- Current, controlled (requiring treatment) or uncontrolled neurological diagnosis, including but not limited to Alzheimer's Disease, other dementias, mild cognitive impairment, Huntington's Disease, Parkinson's Disease, multiple sclerosis, stroke, epilepsy, aphasia, or other condition that in the opinion of the PI may confound study data/assessments.
- Any other medical condition in the last 90 days that in the opinion of the PI may confound study data/assessments.
- Has been under the care of a caretaker or has not been living independently in the last 90 days.
- In the last three years has used online brain training programs (e.g., BrainHQ, Lumosity, Peak) for more than two weeks continuously.
- Known sensitivity (such as headaches, dizziness, nausea) to bright, stimulating video displays.
- History of seizures (excluding febrile seizures), or significant motor or vocal tics, including but not limited to Tourette's Disorder and photo-sensitive epilepsy.
- Visual acuity that cannot be corrected that prevents or negatively impacts computer activity.
- Pregnancy, or strong likelihood of pregnancy.
- Left-handed or ambidextrous.
- Unwillingness or inability to comply with imaging safety protocols. Inability includes but is not limited to metal implants or exposure to shrapnel.
- Any other condition that in the opinion of the PI may confound study data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BOLD response during gameplay
Time Frame: Day 60
|
Whole-brain blood oxygen level-dependent (BOLD) response during gameplay
|
Day 60
|
Responder rates
Time Frame: Day 60
|
Percentage of participants who show A) BOLD response by brain region during gameplay, B) Between-network connectivity, based on BOLD responses, during gameplay, C) Within-network connectivity, based on BOLD responses, during gameplay
|
Day 60
|
Structural MRI volumetrics: Volume
Time Frame: Day 60
|
Volume at rest
|
Day 60
|
Structural MRI volumetrics: Cortical thickness
Time Frame: Day 60
|
Cortical thickness measured in millimeters
|
Day 60
|
Structural MRI volumetrics: Brain-Predicted Age Difference
Time Frame: Day 60
|
Brain-Predicted Age Difference at rest
|
Day 60
|
Behavior response: Game score
Time Frame: Day 60
|
Score on game after completion of gameplay
|
Day 60
|
BAMS-7 (Brief Attention and Mood Scale of 7 Items)
Time Frame: Day 60
|
Subject-reported BAMS-7 (Brief Attention and Mood Scale of 7 Items) including the Attention subscale, Mood subscale, and Total, measured post-imaging
|
Day 60
|
VGPQ (Video Game Playing Questionnaire)
Time Frame: Day 60
|
Subject-reported VGPQ (Video Game Playing Questionnaire) including non-video game playing (NVGP) and video game playing (VGP)
|
Day 60
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kevin Madore, PhD, Lumos Labs, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 15, 2024
Primary Completion (Estimated)
August 31, 2024
Study Completion (Estimated)
August 31, 2024
Study Registration Dates
First Submitted
April 3, 2024
First Submitted That Met QC Criteria
April 18, 2024
First Posted (Actual)
April 19, 2024
Study Record Updates
Last Update Posted (Actual)
April 19, 2024
Last Update Submitted That Met QC Criteria
April 18, 2024
Last Verified
April 1, 2024
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adults
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
King Abdulaziz UniversityUniversity College Dublin; Royal College of Surgeons, IrelandRecruitingHealthy Adults | Healthy NutritionSaudi Arabia
-
S-Infinity Pharmaceuticals Co., LtdRecruiting
-
Auburn UniversityAuburn UniversityRecruiting
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
National Yang Ming UniversityCompleted
-
EicOsis Human Health Inc.CompletedHealthy AdultsUnited States
-
Wecare Probiotics Co., Ltd.Completed
-
University of Massachusetts, AmherstNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
University Hospital Inselspital, BerneCompletedHealthy | AdultsSwitzerland